Details for 2017159560

Up to date per 01.04.2026

Actions

Title / Product Name

VERMEIDUNG UNERWÜNSCHTER NEBENWIRKUNGEN DURCH CD3-SPEZIFISCHE BINDUNGSDOMÄNEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017159560

EP Publication Number

3228315

E-Number

1337490

Language

PCT Number

Publication Date

11.10.2017 A

25.11.2020 B1

Registration Date

25.11.2020

AT Publication Date

15.12.2020

Application Date

27.10.2011

Registration Number

Priorities

10.11.2010

412229 P

IPC

A61K 31/573 20060101AFI20170801BHEP

Maximum Duration of Protection

27.10.2031

Owner

Amgen Research (Munich) GmbHStaffelseestrasse 2 81477 MünchenDE

Representative

No representatives present

Inventor

ZUGMAIER, Gerhardc/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 MuenchenDE

NAGORSEN, Dirkc/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 MuenchenDE

SCHEELE, Juergenc/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 MuenchenDE